RAS mutations drive proliferative chronic myelomonocytic leukemia via activation of a novel KMT2A-PLK1 axis

Carr, R. M.; Vorobyev, D.; Lasho, T.; Marks, D. L.; Tolosa, E. J.; Vedder, A.; Almada, L. L.; Yurchenko, A.; Padioleau, I.; Alver, B.; Coltro, G.; Binder, M.; Safgren, S. L.; Horn, I.; You, X.; Droin, N.; Solary, E.; Balasis, M. E.; Berger, K.; Pin, C.; Witzig, T.; Buradkar, A.; Graf, T.; Valent, P.; Mangaonkar, A. A.; Robertson, K. D.; Howard, M. T.; Kaufmann, S. H.; Fernandez-Zapico, M. E.; Geissler, K.; Padron, E.; Zhang, J.; Nikolaev, S.; Patnaik, M. M.

Links

ORCID

Tools

Export citation

Search in Google Scholar

RAS mutations drive proliferative chronic myelomonocytic leukemia via activation of a novel KMT2A-PLK1 axis

Published in 2019 by R. M. Carr, D. Vorobyev, T. Lasho, D. L. Marks, E. J. Tolosa, A. Vedder, L. L. Almada, A. Yurchenko, I. Padioleau, B. Alver, G. Coltro, M. Binder, S. L. Safgren, I. Horn, X. You and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload